Announcements Trials
Browse Landscape

Phase

Phase 2 30Phase 1 12Phase 1/2 11Phase EARLY_PHASE1 3Phase 3 1Phase 2/3 1

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 10Gastrointestinal 6Head & Neck 4Sarcoma 3Lymphoid 3Genitourinary 3CNS 3Thoracic 2

Conditions

Sarcoma 2Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Kaposi 1Melanoma 1Lymphoma 1Head and Neck Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Magnetic Resonance Spectroscopy 6pembrolizumab 3Specimen Handling 3Radiotherapy 3Oncolytic Virotherapy 3Nivolumab 3Irinotecan 3Cyclophosphamide 3X-Rays 2Temozolomide 2Etoposide 2Doxorubicin 2Biopsy 2Bevacizumab 2trastuzumab biosimilar HLX02 1sodium thiosulfate 1romiplostim 1pertuzumab 1perflutren 1palbociclib 1olaparib 1niraparib 1montelukast 1glucarpidase 1gamma-Glutamyl Hydrolase 1fluorodopa F 18 1eribulin 1entrectinib 1entacapone 1cobimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Nivolumab × Sarcoma × Clear all
NCT03463408 2025-08-11

Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma

University of Rochester

Phase EARLY_PHASE1 Active not recruiting
14 enrolled
Sarcoma

Sarcoma

NCT03316274 2024-06-25

Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma

University of California, San Francisco

Phase EARLY_PHASE1 Completed
12 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT04891718 2022-07-08

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Presage Biosciences

Phase EARLY_PHASE1 Withdrawn
DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡